Data as of .
BIOY vs NUKX: which paid, and which earned it?
BIOY and NUKX both write options for income.
What they hold in common
By the books each fund has filed, BIOY and NUKX hold 0% of their money in the same securities at the same weight.
| Only in BIOY | Only in NUKX |
|---|---|
| Treasury Bill 100.00% | Global X Uranium ETF 20.16% |
| NextEra Energy Inc 7.66% | |
| Dominion Energy Inc 7.42% | |
| Centrus Energy Corp 7.37% | |
| Lightbridge Corp 7.26% | |
| Duke Energy Corp 7.14% | |
| Constellation Energy Corp 6.92% | |
| Uranium Energy Corp 6.88% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
Performance, window by window
| Window | Total return | Cash paid | Against the benchmark | |||
|---|---|---|---|---|---|---|
| BIOY | NUKX | BIOY | NUKX | BIOY | NUKX | |
| 3 months | +2.5% | −19.7% | 14.1% | 2.6% | −9.0 pts | −6.8 pts |
| 6 months | not published | −15.3% | not published | 6.4% | not published | −5.0 pts |
| Since launch | +2.0% | −25.6% | 20.6% | 6.3% | −15.3 pts | −5.7 pts |
| BIOY GraniteShares YieldBOOST Biotech ETF Synthetic covered call on XBI, paying weekly | NUKX Nicholas Nuclear Income ETF Option income on URA, paying weekly | |
|---|---|---|
| Issuer | GraniteShares | Nicholas |
| Strategy | synthetic covered call | option income |
| Benchmark | Biotech (XBI), used as the proxy | Uranium and nuclear (URA), used as the proxy |
| Pays | weekly | weekly |
| Payout rate, annualized | 60.0% | 13.1% |
| Expense ratio | 1.07% | 1.07% |
| Cash paid, 1 year | 20.6% (since launch on May 5, 2026) | 6.3% (since launch on Mar 3, 2026) |
| Price change, 1 year | −19.0% | −30.8% |
| Total return, 1 year | +2.0% (since launch on May 5, 2026) | −25.6% (since launch on Mar 3, 2026) |
| Benchmark return, 1 year | +17.3% | −19.9% |
| Ahead or behind | −15.3 pts | −5.7 pts |
| Return of capital, latest estimate | 96% | not published |
| Age | 136 days | 199 days |
| Net assets | $1m | $2m |
BIOY in plain words
Over the period since launch on May 5, 2026 to Sep 18, 2026, BIOY paid 20.6% of its starting value in cash distributions while its price fell 19.0%. With every distribution reinvested, the fund returned +2.0%. Biotech (XBI), used as the proxy returned +17.3% over the same days, so a holder was behind by 15.3 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 60.0%, paid weekly. GraniteShares estimates that 96% of the distribution paid Aug 25, 2026 was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
NUKX in plain words
Over the period since launch on Mar 3, 2026 to Sep 18, 2026, NUKX paid 6.3% of its starting value in cash distributions while its price fell 30.8%. With every distribution reinvested, the fund returned −25.6%. Uranium and nuclear (URA), used as the proxy returned −19.9% over the same days, so a holder was behind by 5.7 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 13.1%, paid weekly.
Questions people ask
- Which is cheaper, BIOY or NUKX?
- BIOY charges 1.07% a year and NUKX charges 1.07%, so BIOY is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, BIOY against NUKX, data as of Sep 18, 2026. https://etfiq.com/compare/income/bioy-vs-nukx Free to use with attribution; the underlying files are at Open data.